Literature DB >> 3412594

Neuropsychological effects of brain autograft of adrenal medullary tissue for the treatment of Parkinson's disease.

F Ostrosky-Solís1, L Quintanar, I Madrazo, R Drucker-Colín, R Franco-Bourland, V Leon-Meza.   

Abstract

We describe the pre- and postoperative neuropsychological profiles of seven patients who received an autograft of adrenal medullary tissue to the caudate nucleus for the treatment of Parkinson's Disease (PD). The preoperative neuropsychological evaluations revealed specific cognitive deficits of varying degree. The patients showed frontal lobe-type deficits with alterations in behavioral programming leading to difficulties in the organization of motor sequences and alternating programs. They also showed memory disorders and visuospatial and visuoperceptual deficiences such as a loss of figure-ground perspective and fragmentation. Postoperative evaluations, carried out 3 months after neurosurgery, revealed a significant amelioration of the frontal lobe-type symptoms and visuospatial deficits, as well as an improvement in memory tasks that require an active organization of the response. Immediate and delayed memory difficulties remained unchanged. These observations were compared to neuropsychological data obtained from neurologically intact subjects and from unoperated PD patients. The improvements of the operated PD patients resulted in performance levels close to normal values and clearly distinguishable from those of unoperated PD patients, and were unrelated to improved mood, increased alertness, or sustained attention. Autotransplantation of adrenal medullary tissue to the caudate nucleus of PD patients showing a decreased effective response to L-dopa therapy can partially restore motor functions and frontal-type cognitive symptoms.

Entities:  

Mesh:

Year:  1988        PMID: 3412594     DOI: 10.1212/wnl.38.9.1442

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

Review 1.  Cell-based therapies for Parkinson disease—past insights and future potential.

Authors:  Roger A Barker; Janelle Drouin-Ouellet; Malin Parmar
Journal:  Nat Rev Neurol       Date:  2015-08-04       Impact factor: 42.937

Review 2.  Treating Parkinson's disease in the 21st century: can stem cell transplantation compete?

Authors:  Philip C Buttery; Roger A Barker
Journal:  J Comp Neurol       Date:  2014-04-04       Impact factor: 3.215

3.  Amelioration of non-motor dysfunctions after transplantation of human dopamine neurons in a model of Parkinson's disease.

Authors:  M J Lelos; R J Morgan; C M Kelly; E M Torres; A E Rosser; S B Dunnett
Journal:  Exp Neurol       Date:  2016-02-04       Impact factor: 5.330

4.  Transplantation of Human Neural Progenitor Cells (NPC) into Putamina of Parkinsonian Patients: A Case Series Study, Safety and Efficacy Four Years after Surgery.

Authors:  I Madrazo; O Kopyov; M A Ávila-Rodríguez; F Ostrosky; H Carrasco; A Kopyov; A Avendaño-Estrada; F Jiménez; E Magallón; C Zamorano; G González; T Valenzuela; R Carrillo; F Palma; R Rivera; R E Franco-Bourland; G Guízar-Sahagún
Journal:  Cell Transplant       Date:  2018-12-21       Impact factor: 4.064

5.  Defining the unknowns for cell therapies in Parkinson's disease.

Authors:  Emma L Lane; Mariah J Lelos
Journal:  Dis Model Mech       Date:  2022-09-27       Impact factor: 5.732

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.